<DOC>
	<DOCNO>NCT01009515</DOCNO>
	<brief_summary>The number melanoma case steadily increase past decade . For many patient metastatic melanoma , effective therapy . The goal study determine whether combination drug treatment carboplatin , paclitaxel temozolomide effective treatment metastatic recurrent melanoma .</brief_summary>
	<brief_title>Carboplatin , Paclitaxel , Temozolomide Patients With Metastatic Melanoma</brief_title>
	<detailed_description>Over past several decade , significant research conduct try identify active chemotherapeutic agent treatment melanoma . The rationale combining taxanes platinum agent activity melanoma ; vitro clinical data suggest synergy drug use combination wide variety tumor , include melanoma ; toxicity profile agent overlap . Temozolomide ( drug approve treatment melanoma ) combine drug , include taxanes platinum , previous clinical trial melanoma . Specifically , previous phase I study combination temozolomide , paclitaxel , carboplatin melanoma show objective response . The efficacy combination study phase II trial .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>All patient biopsy proven advanced melanoma eligible measurable disease . Patients must life expectancy least 12 week . Prior surgery , immunotherapy , minimal chemotherapy ( 1 drug less 4 month ) , radiotherapy primary tumor acceptable must complete least 4 week study entry , patient completely recover procedure . Patients must Zubrod performance status 02 . Patients must sign informed consent . Patients adequate bone marrow function define absolute peripheral granulocyte count ≥ 1500 cells/mm3 , hemoglobin &gt; 8 g/dl , platelet count ≥ 100 000/mm3 . Patients normal hepatic function total bilirubin &lt; 1.5 upper limit normal ( ULN ) serum glutamic oxaloacetic transaminase ( SGOT ) serum glutamicpyruvic transaminase ( SGPT ) &lt; 2 time upper limit normal ( ULN ) , adequate renal function define serum creatinine ≤ 1.5 time ULN . Men woman childbearing potential must willing consent use effective contraception treatment least 3 month . Patients brain metastasis eligible appropriately treat , asymptomatic Pregnant woman nurse mother eligible . Patients must receive concurrent chemotherapy radiation trial . Patients severe medical problem would interfere therapy eligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>metastatic</keyword>
	<keyword>melanoma</keyword>
	<keyword>skin cancer</keyword>
	<keyword>paclitaxel</keyword>
	<keyword>carboplatin</keyword>
	<keyword>temozolomide</keyword>
</DOC>